ArticleEuropean heart journal. Cardiovascular pharmacotherapy2022

Aspirin, NOACs, warfarin: which is the best choice to tackle cognitive decline in elderly patients? Insights from the GIRAF and ASCEND-Dementia trials presented at the AHA 2021.

Pasquale Mone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.